The pathogenesis of systemic sclerosis

被引:0
|
作者
Huber, LC [1 ]
Distler, JHW [1 ]
Gay, S [1 ]
Distler, O [1 ]
机构
[1] Univ Spital Zurich, WHO, Collaborating Ctr Mol Biol & Novel Therapeut Stra, Zentrum Expt Rheumatol, Zurich, Switzerland
关键词
systemic sclerosis; fibrosis; angiogeneris; autoantibodies; cellular immunity; regulation of collagen genes;
D O I
10.1055/s-2005-858834
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Systemic sclerosis (SSc) is an uncommon, complex, multisystemic disorder, characterized by severe fibrosis of the skin and various internal organs. As in other collagenoses, the etiology of SSc is unknown and the exact mechanisms involved in the pathogenesis are not well understood. For the clinical and pathogenetic manifestations, however, the following key processes have been identified: 1) excessive accumulation of collagen and other components of the extracellular matrix; 2) early morphological changes in small blood vessels; and 3) alterations in the cellular and humoral immune response resulting in the production of disease-specific antibodies. Currently, it remains unclear how these processes interact, to cause a chronic and progressive fibrotic disease. Continued research, has however yielded substantial insight into the molecular understanding of several basic mechanisms, suggesting novel therapeutic targets for the future.
引用
收藏
页码:15 / 23
页数:9
相关论文
共 50 条
  • [31] Current frontiers in systemic sclerosis pathogenesis
    Ciechomska, Marzena
    van Laar, Jacob
    O'Reilly, Steven
    EXPERIMENTAL DERMATOLOGY, 2015, 24 (06) : 401 - 406
  • [32] Fibroblast abnormalities in the pathogenesis of systemic sclerosis
    Usategui, Alicia
    del Rey, Manuel J.
    Pablos, Jose L.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2011, 7 (04) : 491 - 498
  • [33] Vascular changes in the pathogenesis of systemic sclerosis
    Distler, JHW
    Kalden, JR
    Gay, S
    Distler, O
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2004, 63 (06): : 446 - 450
  • [34] Role of Epigenetics in the Pathogenesis of Systemic Sclerosis
    Liu Chao-Fan
    Tang Jia-Xuan
    Zhu Lu-Bing
    Li Ming
    国际皮肤性病学杂志(英文), 2022, 05 (02)
  • [35] New developments in the pathogenesis of systemic sclerosis
    Sakkas, LI
    AUTOIMMUNITY, 2005, 38 (02) : 113 - 116
  • [36] Advances in pathogenesis and treatment of systemic sclerosis
    Denton, Christopher P.
    CLINICAL MEDICINE, 2016, 16 (01) : 55 - 60
  • [37] New insights into the pathogenesis of systemic sclerosis
    Tamby, MC
    Chanseaud, Y
    Guillevin, L
    Mouthon, L
    AUTOIMMUNITY REVIEWS, 2003, 2 (03) : 152 - 157
  • [38] Epigenetic Modifications in the Pathogenesis of Systemic Sclerosis
    Yu, Jiangfan
    Tang, Rui
    Ding, Ke
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2022, 15 : 3155 - 3166
  • [39] Role of Alarmins in the Pathogenesis of Systemic Sclerosis
    Giovannetti, Antonello
    Straface, Elisabetta
    Rosato, Edoardo
    Casciaro, Marco
    Pioggia, Giovanni
    Gangemi, Sebastiano
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (14) : 1 - 24
  • [40] PATHOGENESIS OF PROGRESSIVE SYSTEMIC-SCLEROSIS
    HAUSTEIN, UF
    HERRMANN, K
    BOHME, HJ
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 1986, 25 (05) : 286 - 293